Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome

CONTEXT: Patients with von Hippel-Lindau (VHL) syndrome have a 25–30% chance of developing pheochromocytoma. Although practice guidelines recommend biochemical and radiological screening every 1–2 years for pheochromocytoma in patients with VHL, there are limited data on the optimal age and frequenc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Endocrinol Metab
Autores principales: Aufforth, Rachel D., Ramakant, Pooja, Sadowski, Samira M., Mehta, Amit, Trebska-McGowan, Katarzyna, Nilubol, Naris, Pacak, Karel, Kebebew, Electron
Formato: Artigo
Lenguaje:Inglês
Publicado: Endocrine Society 2015
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4667160/
https://ncbi.nlm.nih.gov/pubmed/26451910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-3045
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares